WALA baume nasal tb 10 g

7680415840175 CH-41584 20.02.
WALA baume nasal tb 10 g
WALA baume nasal tb 10 g
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
4158401
CPT
-
Packaging group
10
Unit
g
Composition
berberis vulgaris e fructibus rec. ferm 33c TM (HAB 33c) 100 mg, prunus spinosa e fructibus recens LA 25% (HAB 12o) 50 mg, balsamum peruvianum (Myroxylon balsamum var pereirae (Royle) Harms, balsamum) 5 mg, cajeputi aetheroleum (Melaleuca leucadendra (L.)L., aetheroleum) 25 mg, eucalypti aetheroleum (Eucalyptus globulus Labill., Eucalyptus polybractea R.T. Baker, Eucalyptus smithii R.T. Baker, aetheroleum) 25 mg, silicea colloidale (ex liquor natrii silicici et acidum citricum monohydricum) 5 mg, adeps lanae 460 mg, olivae oleum virginale, aqua purificata, ethanolum 96 per centum, lecithinum ex soja, ad unguentum pro 1 g, corresp. ethanolum 2 % m/m.

Articles (1)

Wala Nasenbalsam, Nasencreme
Nasencreme
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/01/2026
Patient information leaflet
Français
15/01/2026
Patient information leaflet
Italien
15/01/2026

Detailed composition

Substance Quantity Type Category
berberis vulgaris e fructibus rec. ferm 33c
100.0 MG Substance Wirkstoff (Principe actif)
prunus spinosa e fructibus recens LA 25% (HAB 12o)
50.0 MG Substance Wirkstoff (Principe actif)
balsamum peruvianum
5.0 MG Substance Wirkstoff (Principe actif)
cajeputi aetheroleum
25.0 MG Substance Wirkstoff (Principe actif)
eucalypti aetheroleum
25.0 MG Substance Wirkstoff (Principe actif)
silicea colloidale (ex liquor natrii silicici et acidum citricum monohydricum)
5.0 MG Substance Wirkstoff (Principe actif)
adeps lanae
460.0 MG Substance HBESI
olivae oleum virginale
- Substance HNIDK
aqua purificata
- Substance HNIDK
ethanolum 96 per centum
- Substance HBESI
lecithinum ex soja
- Substance HNIDK

Authorization holder

WALA Schweiz AG

3011 Bern

Authorization information

Swissmedic authorization number
41584
Drug name
Wala Nasenbalsam, Nasencreme
Galenic form
NASA
Authorization status
Z
Dispensation category
D
First authorization
12/08/1980
Authorization expiration date
31/12/9999
IT number
20.02.
Domain
Human medicine
Field of application
Gemäss der anthroposophischen Menschen- und Naturerkenntnis bei Schnupfen und Entzündungen der Nasenschleimhaut.

Packaging details

Description (FR)
WALA baume nasal tb 10 g
Description (DE)
WALA Nasenbalsam Tb 10 g
Market launch
12/08/1980
Narcotic (BTM)
No
Buy us a coffee Explore the data